Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

Author: BerrocosoEsther, Gibert-RaholaJuan, MicóJuan Antonio, Rojas-CorralesM Olga

Paper Details 
Original Abstract of the Article :
Tramadol is a centrally acting analgesic that demonstrates opioid and monoaminergic properties. Several studies have suggested that tramadol could play a role in mood improvement. Moreover, it has previously been shown that tramadol is effective in the forced swimming test in mice and the learned he...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15358985

データ提供:米国国立医学図書館(NLM)

Exploring the Antidepressant Potential of Tramadol and Its Enantiomers

The desert of mental health research is vast, and we're constantly searching for new ways to combat depression. This study investigates the antidepressant-like effects of tramadol, a medication primarily known for its analgesic properties. Tramadol, a fascinating molecule, has been shown to have both opioid and monoaminergic properties, making it a potential candidate for tackling depression.

The researchers used the reserpine test, a classic method for screening antidepressant drugs. They compared the effects of tramadol and its enantiomers (mirror-image forms) with those of established antidepressants like desipramine, fluvoxamine, and venlafaxine, as well as with opiates like morphine and methadone.

The results revealed that both racemic tramadol and its (-)-enantiomer demonstrated antidepressant-like effects in the reserpine test, comparable to those seen with clinically effective antidepressants. This suggests that tramadol might have an inherent antidepressant potential, independent of its analgesic effects.

The Promise of Tramadol as an Antidepressant

This research offers intriguing possibilities for the treatment of depression. The study's findings indicate that tramadol, particularly its (-)-enantiomer, could hold promise as a new therapeutic option for individuals struggling with depression.

Navigating the Desert of Depression

This research is a beacon of hope in the vast desert of depression. It suggests that tramadol, a medication already used for pain relief, could also hold potential for treating depression. Further research is crucial to fully explore its antidepressant properties and determine its safety and efficacy in clinical settings.

Dr.Camel's Conclusion

This study is a reminder that the desert of mental health research is full of surprises. We must continue to explore the potential of existing medications and their unique properties in order to find new ways to combat depression. As with the search for an oasis in the desert, we must be persistent and resourceful in our pursuit of effective treatments for mental illness.

Date :
  1. Date Completed 2005-03-17
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

15358985

DOI: Digital Object Identifier

18/3/404

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.